Skip to main content

Table 1 Base Line Characteristics of the Patients*

From: Concomitant therapy with Cineole (Eucalyptole) reduces exacerbations in COPD: A placebo-controlled double-blind trial

CHARACTERISTIC

PLACEBO

(N = 110)

CINEOLE

(N = 110)

Age – yr

  

   Mean

62.5 ± 10.2

62.2 ± 9.1

   Range

40 – 79

41 – 79

Sex – M/F

75/35

66/44

Weight – kg

  

   Mean

79 ± 16

79 ± 14

   Range

48 – 120

52 – 113

Height – m

  

   Mean

1.71 ± 8.8

1.70 ± 8.0

   Range

1.48 – 1.90

1.54 – 1.92

Years since appearance of COPD

  

   Mean

12.8 ± 9.7

13.6 ± 10.9

   Range

1 – 56

1 – 59

Severity of COPD [number of patients]

  

   Moderate COPD (II)

69

68

   Severe COPD (III)

41

42

FEV1/VC [%]

58.0

58.7

FEV1 [l]

1.61 ± 0.5

1.62 ± 0.5

FEV1 % predicted value

54.4

54.9

Reversibility (increase of FEV1 after inhalation of β-agonist) [%]

5.5

4.5

Allergies (number)

10

9

Pack years

31.5 ± 19

31.3 ± 16

  1. * Plus – minus values are means ± SD.